Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation

BackgroundWe have reported that the glucosamine suppressed the proliferation of the human prostate carcinoma cell line DU145 through inhibition of STAT3 signaling. DU145 cells autonomously express IL-6 and the IL-6/STAT3 signaling is activated. IL-6 receptor subunits are subject to N-glycosylation, a posttranslational modification which is important for protein stability and function. We speculated that the inhibition of STAT3 phosphorylation by glucosamine might be a functional consequence of the reduced N-glycosylation of gp130.MethodsThe human prostate cancer cell lines DU145 and PC-3 and human melanoma cell line A2058 were used in this study. Glucosamine effects on N-glycosylation of glycoproteins were determined by Western blot analysis. IL-6 binding to DU145 cells was analyzed by flow cytometry. The cell proliferation suppression was investigated by colorimetric Janus green staining method.ResultsIn DU145 cells glucosamine reduced the N-glycosylation of gp130, decreased IL-6 binding to cells and impaired the phosphorylation of JAK2, SHP2 and STAT3. Glucosamine acts in a very similar manner to tunicamycin, an inhibitor of protein N-glycosylation. Glucosamine-mediated inhibition of N-glycosylation was neither protein- nor cell-specific. Sensitivity of DU145, A2058 and PC-3 cells to glucosamine-induced inhibition of N-glycosylation were well correlated to glucosamine cytotoxicity in these cells.ConclusionOur results suggested that the glucosamine-induced global inhibition of protein N-glycosylation might be the basic mechanism underlying its multiple biochemical and cellular effects.

[1]  H. Freeze,et al.  Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. , 2008, Cancer Research.

[2]  Richard M Caprioli,et al.  Characterization of glycosylation sites of the epidermal growth factor receptor. , 2003, Biochemistry.

[3]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[4]  Hua Yu,et al.  The STATs of cancer — new molecular targets come of age , 2004, Nature Reviews Cancer.

[5]  P. Plagemann,et al.  Cytochalasin B: inhibition of glucose and glucosamine transport. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Moritz,et al.  Determination of the Disulfide Structure andN-Glycosylation Sites of the Extracellular Domain of the Human Signal Transducer gp130* , 2001, The Journal of Biological Chemistry.

[7]  R. Yu,et al.  N-glycans modulate the activation of gp130 in mouse embryonic neural precursor cells. , 2009, Biochemical and biophysical research communications.

[8]  J. H. Quastel,et al.  Inhibition of Tumour Growth by D-Glucosamine , 1953, Nature.

[9]  R. Perez-soler,et al.  Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib , 2009, Cancer Chemotherapy and Pharmacology.

[10]  A. Varki,et al.  Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.

[11]  Naoyuki Taniguchi,et al.  Functional roles of N‐glycans in cell signaling and cell adhesion in cancer , 2008, Cancer science.

[12]  G. Scali,et al.  Glucosamine sulphate: a controlled clinical investigation in arthrosis. , 1981, Pharmatherapeutica.

[13]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.

[14]  T. Shiraishi,et al.  Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. , 2005, Cancer research.

[15]  R. Winzler,et al.  Inhibitory effects of D-glucosamine on the growth of Walker 256 carcinosarcoma and on protein, RNA, and DNA synthesis. , 1970, Cancer research.

[16]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[17]  Robert J. Gillies,et al.  Causes and Consequences of Increased Glucose Metabolism of Cancers , 2008, Journal of Nuclear Medicine.

[18]  Z. Estrov,et al.  Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells , 2005, British Journal of Cancer.

[19]  K. Itakura,et al.  Glucosamine suppresses proliferation of human prostate carcinoma DU145 cells through inhibition of STAT3 signaling , 2009, Cancer Cell International.

[20]  A. Tarentino,et al.  Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F. , 1985, Biochemistry.

[21]  W McDowell,et al.  Dissecting glycoprotein biosynthesis by the use of specific inhibitors☆ , 1988, Biochimie.

[22]  J. Turkson,et al.  Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein , 2006, Molecular Cancer Therapeutics.

[23]  J. Pow-Sang,et al.  Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells. , 2002, Cancer research.

[24]  L. Klampfer,et al.  Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. , 2006, Current cancer drug targets.

[25]  J. Downward,et al.  Autophosphorylation sites on the epidermal growth factor receptor , 1984, Nature.

[26]  Bourke Ca,et al.  Experimental tunicamycin toxicity in cattle, sheep and pigs , 1993 .

[27]  R. Oyasu,et al.  Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. , 1997, Cancer research.

[28]  R. Schwarz,et al.  Glucosamine itself mediates reversible inhibition of protein glycosylation. A study of glucosamine metabolism at inhibitory concentrations in influenza-virus-infected cells. , 1979, European journal of biochemistry.